Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AZD-6280 是一种新型的亚型选择性 GABAAα2/3 受体阳性调节剂,用于治疗广泛性焦虑症。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 2,990 | 现货 | ||
5 mg | ¥ 5,990 | 现货 | ||
10 mg | ¥ 8,290 | 现货 | ||
25 mg | ¥ 12,300 | 现货 | ||
50 mg | ¥ 16,500 | 现货 | ||
100 mg | ¥ 22,300 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 6,520 | 现货 |
产品描述 | AZD6280 is a novel, subtype-selective GABAAα2/3 receptor positive modulators, used for treatment of generalized anxiety disorder. |
体内活性 | The [11C]flumazenil binding was reduced in a dose-dependent, saturable manner by AZD6280. Maximum receptor occupancy could be reached for AZD6280 without causing sedation or cognitive impairment. The K i,plasma estimates for AZD6280 was 440 nmol/l[1]. |
动物实验 | Two PET studies, using high-resolution research tomography (HRRT) and the radioligand [11C]flumazenil, were performed in 12 subjects at baseline and after administration of single oral doses of AZD7325 (0.2 to 30 mg) and AZD6280 (5 to 40 mg). PET images were analyzed using a simplified reference tissue model, and regional binding potentials (BPND) were obtained. The relationship between plasma concentration of AZD7325 or AZD6280 and GABAA receptor occupancy was described by hyperbolic function, and K i,plasma (plasma concentration required for 50% receptor occupancy) was estimated. Assessments of safety and tolerability included recording of adverse events, vital signs, electrocardiogram, and laboratory tests[1]. |
分子量 | 366.41 |
分子式 | C20H22N4O3 |
CAS No. | 942436-93-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (68.23 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.7292 mL | 13.6459 mL | 27.2918 mL | 68.2296 mL |
5 mM | 0.5458 mL | 2.7292 mL | 5.4584 mL | 13.6459 mL | |
10 mM | 0.2729 mL | 1.3646 mL | 2.7292 mL | 6.823 mL | |
20 mM | 0.1365 mL | 0.6823 mL | 1.3646 mL | 3.4115 mL | |
50 mM | 0.0546 mL | 0.2729 mL | 0.5458 mL | 1.3646 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
AZD-6280 942436-93-3 Membrane transporter/Ion channel Neuroscience GABA Receptor γ-Aminobutyric acid Receptor inhibit Gamma-aminobutyric acid Receptor Inhibitor AZD 6280 AZD6280 inhibitor